title: Reply: 'Behr syndrome' with OPA1 compound heterozygote mutations.
authors.affiliation: 1 Departments of Neurology and Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, UK 2 Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK Patrick.Yu-Wai-Man@ncl.ac.uk.
authors.forename: Patrick
authors.initials: P
authors.lastname: Yu-Wai-Man
authors.affiliation: 1 Departments of Neurology and Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, UK 2 Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
authors.forename: Patrick F
authors.initials: PF
authors.lastname: Chinnery
mesh_terms: D002493:Central Nervous System Diseases / Q000150:complications*; D005260:Female; D020558:GTP Phosphohydrolases / Q000235:genetics*; D006801:Humans; D008297:Male; D029241:Optic Atrophy, Autosomal Dominant / Q000150:complications*
chemical_list: D020558:GTP Phosphohydrolases